LoginSign up

Approved revisions

From The Embassy of Good Science

View list of: Pages whose approved revision is not their latest | Unapproved pages | All pages with an approved revision | Pages with invalid approvals | Files whose approved revision is not their latest | Unapproved files | All files with an approved revision | Files with invalid approvals

50 ss ordered by recently added

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
  1. Gender bias
  2. Forensic Statistics to detect Data Fabrication
  3. Importance of healthy lifestyle
  4. Questionable Research Practices in Analysis and Reporting
  5. Ethical Challenges of AI-Driven Neurotechnology Devices
  6. Predatory publishing
  7. How to be a good lab partner
  8. Retractions: correcting the scientific literature
  9. Qualitative research
  10. Virtues in research integrity
  11. Privacy in research
  12. Inappropriate authorship
  13. Grading the quality of evidence in clinical practice guidelines
  14. Research Integrity champions
  15. Selective citation
  16. The decision on ice
  17. Insufficiently reported study flaws and limitations
  18. Faking it in academia- the rise of authorship fraud
  19. Prospective registration of clinical trials
  20. Fabrication
  21. The impact of the GDPR on scientific data
  22. The Rise of Octopus Affiliation: Navigating Multiple Institutional Associations in Academic Publishing
  23. Dialogue versus debate
  24. Initiatives promoting research integrity
  25. Dutch National Survey on Research Integrity
  26. Collaboration In Research
  27. Discipline specific codes and guidelines on research integrity
  28. Monitoring funding processes
  29. Data management plans
  30. Consent and assent for research on children
  31. The learning curve - theatre play #MeTooAcademia
  32. P-value hacking
  33. Convenience sampling as an ethical concern
  34. Conflict of interests
  35. The influence of pharmaceutical company on drug availability
  36. Science policy
  37. Consent and Assent for Research on Children
  38. Poor mentoring or supervision of early career researcherers
  39. Networks and projects promoting research integrity
  40. Sponsorship of drug and device studies by the manufacturing company
  41. Collaborative working
  42. Superb Supervision: integrity training for supervisors
  43. H-index
  44. (re)submitting without consent of all authors
  45. Not acknowledging contributors who do not qualify for authorship
  46. Communicate results to the general public before a peer reviewed publication is available
  47. Journal Impact Factor
  48. Outcome reporting bias
  49. Replicability
  50. Research with children
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://embassy.science:443/wiki/Special:ApprovedRevs"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
More information

Your platform for research integrity and ethics

Privacy statementTerms of serviceTake down policyContact
Let us keep you posted

Bluesky Logo.svg

The EnTIRE and VIRT2UE projects have received funding from the European Union’s Horizon 2020 research programme under grant agreements N 741782 and N 787580.

5.6.0